Security key
88427A107
THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD)
CUSIP: 88427A107
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 40,245,021
- Total 13F value
- $523,185,278
- Share change
- +2,345,440
- SEC-reported price per share
- $13.00
- Number of holders
- 75
- Value change
- +$31,240,244
- Number of buys
- 44
- Number of sells
- 26
- Shares outstanding
- 45,416,671
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q2 2024
Institutions
75
Top holders
10
THRD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Third Harmonic Bio, Inc. SEC filings
Third Harmonic Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88427A107
Recent filing periods:
Ownership snapshot
Top reported holders of THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Atlas Venture Life Scienc...
Disclosed value leader
Atlas Venture Life Scienc...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 24%
Showing 1-6 of 15 holder rows.
Quick read
Atlas Venture Life Science Advisors, LLC leads the comparable SEC ownership view at 24%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Atlas Venture Life Science Adviso...
24%
ORBIMED ADVISORS LLC
13%
BVF INC/IL
9.6%
EcoR1 Capital, LLC
7%
GENERAL ATLANTIC, L.P.
6.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
24%
|
$102,970,189
10,907,859 shares
|
— | 31 Mar 2024 |
| ORBIMED ADVISORS LLC |
3/4/5
13F
Director, 10%+ Owner · Company
|
13%
from 13F
|
$59,522,120
5,779,071 shares
|
— | 19 Sep 2022 |
| BVF INC/IL |
13F
Company
|
9.6%
|
$41,214,408
4,365,933 shares
|
— | 31 Mar 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
7%
|
$30,042,271
3,182,444 shares
|
— | 31 Mar 2024 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
6.5%
|
$27,930,713
2,958,762 shares
|
— | 31 Mar 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4.5%
|
$19,192,049
2,033,056 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
75
Shares
40,245,021
Rows available
75
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
69
Q2 2024 holders
75
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend